|
 |
|
|
|
|
ANNOUNCEMENTS |
|
1. Proposals Utilizing Epic/eCare |
If you are planning a research project that relies on Epic (development/ configuration, integrating external applications with Epic, using MyChart/Patient Gateway functionality to contact patients, decision support) you are required to contact the PeC Research Team at – PeC Research Team – at the earliest stages of the planning and conception of your proposal to determine feasibility and next steps.
|
|
2. Program in Clinical and Translational Science (PCaTS) |
Program Duration: July 2016 - May 2018
Applications Due: January 8, 2016
This two-year certificate program consists of a didactic curriculum and a mentored clinical/translational (C/T) research project with a Harvard-based mentor. It is designed primarily for clinicians and researchers seeking to strengthen their knowledge in the conduct of C/T investigation.
For more information, please click here.
|
|
3. PCORI Update: CE Opportunity, PCORI in JAMA, Infectious Disease Webinar |
Please click here to read the latest news from the Patient-Centered Outcomes Research Institute.
|
|
|
EVENTS |
|
1. Cardiovascular Research Seminar |
Tuesday, December 1, 1:00pm, CNY 149, Room 2.204
Transcriptional control of cardiac cell fate
Laurie Boyer, PhD
Associate Professor of Biology
MIT
|
|
2. Munn Nursing Research Grand Rounds |
Thursday, December 3, 1:30 - 2:30 pm, O’Keeffe Auditorium
“Exploring the Experience and Impact of Therapeutic Touch Treatments to Nurse Colleagues”
Presented by: Amanda Bulette Coakley, RN, PhD, FNAP, Staff Specialist, Department of Nursing, Patient Care Services
This presentation will discuss how nurses may benefit from therapeutic touch as an alternative method of self-healing, particularly nurses who provide care for acute and chronically ill patients.
Norman Knight Nursing Center for Clinical and Professional Development at Massachusetts General Hospital (OH-239, 10/1/2017) is an approved provider of continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
The learner must stay for the entire program and submit a completed evaluation to obtain contact hours.
|
|
3. MGH Research Council |
Monday, December 7, 12:00 - 1:00 PM, Simches Auditorium (3.110)
Broadcast to Isselbacher Auditorium (CNY-149, 7th Floor)
Crowd Funding
Michele Gagne, Senior Director, Information Systems, MGH Development Office
What’s on Your Mind?
An Open Discussion with the Elected ECOR Representatives
(Lunch available at 11:45 AM)
All MGH Researchers welcome!
|
|
4. Boston Biomedical Innovation Center (B-BIC) Pitch Day |
Wednesday, December 9, 2:00 - 4:00 pm, Simches 3.120
Do you have an idea that you believe has commercial potential?
Join the Boston Biomedical Innovation Center (B-BIC) at Pitch Day. Pitch Day will be held on December 9, Wednesday, 2-4pm, at Massachusetts General Hospital, Simches Building, Room 3120, 185 Cambridge Street, Boston, MA.
Schedule a 20-minute session with our team of experts, including Project Managers and Coaches, who will provide industry viewpoints. You will also learn if B-BIC funding is a good fit for your research. B-BIC is focused on research addressing heart, lung, blood, and sleep disorders, conducted in collaboration with our partner organizations.
Learn more about B-BIC, including current B-BIC award recipients: http://www.b-bic.org/
To schedule your session, please email Pam Keddy: pkeddy@partners.org |
|
5. MGH ORCD RCR Series: Responsible Authorship |
Tuesday, December 15, 2015, 12:00 - 1:00 pm, Charlestown Navy Yard, details provided upon registration
The Center for Faculty Development's Office for Research Career Development presents a seminar for HMS faculty and trainees.
Responsible Authorship
As a researcher, your publication record is critical for career advancement. This seminar in the ORCD’s Responsible Conduct of Research series will cover topics in authorship of science manuscripts, including:
• Guidelines for assigning authors on a manuscript
• Grey areas in authorship decisions
• Case studies of authorship disputes and resolutions
• Tips for successful collaborations and authorship determination
Speaker: David M. Langenau, PhD, Associate Professor of Pathology and Director, Molecular Pathology Unit
Please click here to register by Thu, Dec 10.
Note: This seminar counts as one of the four required lectures in part III of Partners RCR training. All are welcome, but space is limited and registration preference will be given to those with RCR training requirements.
|
|
6. Introduction to Proteomics and Metabolomics |
Tuesday, February 2, 2016, 1:30 - 5:00pm, Simches Room 3.110
Sponsored by the MGH Division of Clinical Research and the Harvard Catalyst
This introductory course is intended for clinicians, investigators, graduate and medical students, and clinical research staff with an interest in functional genomics and precision medicine.
It will introduce fundamental language and concepts including basic concepts behind analytical tools, sample preparation, quantitative considerations, protein-protein interaction networks, post-translational modifications, data analysis, biomarker discovery and validation, translational introduction of diagnostic and prognostic biomarkers into the clinic, approaches to understand basic disease mechanisms and to identify potential novel drug targets, as well as applications for personalized medicine.
Key principles necessary for basic, clinical, and translational researchers to design proteomic and metabolomics studies and to perform and analyze data will be discussed.
View Course Agenda here.
Registration is required. Contact Jillian Tonelli with any questions.
|
|
|
FUNDING OPPORTUNITIES |
|
1. MGH ECOR Deliberative Interim Support Funding |
The Executive Committee on Research (ECOR) is accepting applications for the December 1st deadline for the Deliberative Interim Support Funding. December is the 1st of three standing deadlines for these awards in Fiscal Year 2016. The next deadline will be April 1, 2016.
What are they?
Deliberative Interim Support Funding
This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense). Investigators must have applied for independent, long-term support (R01, R21, U01 and P01). The Deliberative Interim Support process is open to:
-
Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
-
Investigators whose grants received scores >20th percentile.
-
Investigators who were awarded Formulaic Bridge Funding (grants with scores < or = 20th percentile), and are now requesting additional financial support (in excess of $75,000 for RO1s, and $37,500 for R21s).
-
Investigators who have already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application and are now requesting support for their A1 or A0 resubmission. Investigators in this category must apply through the Deliberative Interim Support process for their A1 and A0 resubmission regardless of the score they received on their resubmitted grant.
When is the deadline?
Tuesday, December 1, 2015 - 5:00 PM
How do I learn more and apply?
Deliberative Interim Support Funding - Click here
|
|
2. Limited Submission Funding Opportunities |
We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.
Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org. In addition to your LOI, please include an NIH Biosketch.
The letter of intent should include:
-
Name of the Principal Investigator with appropriate contact information
-
A descriptive title of the potential application
-
Brief description of the project
-
Brief description of why you specifically should be selected to receive institutional nomination for this award
In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.
Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.
-
Superfund Hazardous Substance Research and Training Program (P42)
-
International Centers of Excellence for Malaria Research (U19)
If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.
|
|
3. NIH Update for Week Ending November 27, 2015 |
For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm
|
|
In Case You Missed It |
|
Reminders of recently posted funding opportunities, deadlines and events |
Massachusetts Eye and Ear Gliklich Innovation Scholars Program
Application Deadline: February 1, 2016
Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals
Innovation at Partners HealthCare: Fall Newsletter
Information Systems News - Fall 2015
ORCD Information Session: Career Pathways for Postdocs (CPP) Pilot – December 1
Basic Biostatistics for Clinical Research - January 7, 14, 21, 28, February 4
Introduction to ‘Omics’ Research - March 7 - 11
Looking for something you saw in a previous Research News release? Check out our archive!
|
|
|
|
|
|
|